FDA Investigator: Jacqueline M. Diaz Albertini
- Jacqueline M. Diaz Albertini first started conducting FDA inspections in 2021, with the last inspection in 2022. Over that time, Jacqueline M. Diaz Albertini has conducted 7 inspections at 7 companies across 7 sites.
Get Jacqueline Diaz Albertini's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Grifols Diagnostic Solutions, Emeryville | Dec 2021
Available Now - $199
Jacqueline M. Diaz Albertini
Biologic Form 483
FDA 483 Immucor, Peachtree Corners | July 2021
Available Now - $199
Jacqueline M. Diaz Albertini
Biologic Form 483
FDA 483 Novartis Gene Therapies, Libertyville | June 2021
Available Now - $199
Jacqueline M. Diaz Albertini
Biologic Form 483
FDA 483 Spark Therapeutics, Inc., Philadelphia | 2022
Out-of-stock
Jacqueline M. Diaz Albertini
Biologic Form 483
FDA 483 Jubilant HollisterStier LLC, Spokane | 2021
Out-of-stock
Jacqueline M. Diaz Albertini
Biologic Form 483
Co-Investigators (13)
- Steven E. Bowen, FDA Investigator
- Jacqueline M. Diaz Albert, FDA Investigator
- Brentley S. Collins, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator
- Diaz Albertini, Jacqueline M, FDA Investigator
- Eileen A. Liu, FDA Investigator
- Lewis K. Antwi, FDA Investigator
- Lily Y. Koo, FDA Investigator
- Graeme E. Price, FDA Investigator
- Zhaohui Ye, FDA Investigator
- David E. Bailey, FDA Investigator
- Laurel A. Beer, FDA Investigator
- Burnell M. Henry, FDA Investigator